iGambit
  Feb 15, 2017   MARKET WIRE, NEW YORK
  Aug 26, 2016   MARKET WIRE, NEW YORK
  Nov 10, 2015   MARKET WIRE, NEW YORK
  Nov 11, 2015   MARKET WIRE, NEW YORK
  May 19, 2015   OTC Markets, NEW YORK
  May 13, 2015   OTC Markets, NEW YORK
  April 3, 2012   MARKET WIRE, NEW YORK

  Nov 17, 2011   MARKET WIRE, NEW YORK
  Aug 17, 2011   MARKET WIRE, NEW YORK
  July 19, 2011   MARKET WIRE, NEW YORK
  Oct 22, 2009    REUTERS, NEW YORK
  July 12, 2009   BUSINESS WIRE, NEW YORK
View on Market Wire
Feb 15, 2017

iGambit Announces Acquisition of HUBCENTRIX INC. A Leading Provider of Healthcare Technology

SMITHTOWN, NY--(Marketwired - Feb 15, 2017) - iGambit Inc. (OTCQB: IGMB) announced that on February 14, 2017 it acquired HubCentrix, Inc. (HubCentrix) via a Stock Exchange Agreement.

A copy of the Form 8-K report may be accessed at www.sec.gov.

HubCentrix will initially operate as a wholly-owned subsidiary of iGambit and the name will be changed to HealthDatix Inc. ("HealthDatix").

iGambit also hopes to close on the acquisition of CyberCare Health Division from EncounterCare Solutions, Inc. ("ECSL") within the next thirty (30) days. The Letter of Intent entered into with ECSL was previously announced on August 15, 2016. A copy of the Form 8-K report may be accessed at www.sec.gov

The acquisition of HubCentrix and the CyberCare Health Network Chronic Care Management System provides a new and unique opportunity for physicians to identify patients eligible for both "Annual Wellness Visits" as well as "Chronic Care Management" both of which are reimbursed by Medicare.

The goal of HealthDatix will be to identify the patient's eligibility for Medicare reimbursed doctor visits to access and assist in the well-being and cultivation of a healthy lifestyle. Additionally HealthDatix will be able to provide an FDA approved, Medicare covered platform, for continuous management of chronic care patients. Our continuous care platform will be tailored for individual care and health management of patients susceptible to chronic illness. This will include CyberCare's wearable medical watch.

John Salerno, Chairman of iGambit, stated: "We are very pleased to have this new business opportunity which we believe will increase our stockholders value. Our management team and advisors are very accomplished at introducing and administering rapid growth technology services. We anticipate that our exciting newly combined entity HealthDatix, will have the professionals in place to competently deal with the accelerated growth curve necessary to meet the needs of physician community throughout the country.

Jerry Robinson, President of HubCentrix, stated that he is excited to team up with the management group at iGambit. The combined management team will consolidate to provide an extremely focused group effort to plan and execute corporate strategies for HealthDatix moving forward. My personal background is in marketing management as well as product launch, two areas that I am truly excited to bring to our new products rollout. One of the HealthDatix goals will be to initiate a progressive and effective marketing campaign to introduce our newly combined services to the healthcare marketplace and insurance industry.

About HubCentrix: is located in St. Petersburg, Florida and serves clients throughout the U.S. The company has been at the forefront of web-based collaboration and digital asset management. HubCentrix has a special expertise in streamlining the process of capturing and managing information in the document-intensive medical field.

About iGambit Inc.: iGambit (OTCBB: IGMB) is a fully reporting publicly-held company. iGambit (OTCQB: IGMB) is a fully reporting publicly-held company. We are a diversified company pursuing specific technology strategies and objectives. These objectives have included, among others, the acquisition of early-stage technology companies with strong growth potential easily recognized in the public arena. We believe that the back-ground of our management and of our Board of Directors in the technology markets is a valuable resource that makes us a desirable business partner. We expect to work to assume an active role in the development and growth of the new company, providing both strategic guidance and operational support. The management of iGambit believes that it can leverage its collective expertise to help position the combined company to produce high-margin, recurring and predictable earnings and generate long-term value for our stockholders. For more information, please visit www.igambit.com. Information on our web-site does not comprise a part of this press release.

Cautionary Note Regarding Forward-Looking Statements

Certain statements in this document and elsewhere by iGambit are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such information includes, without limitation, the business outlook, assessment of market conditions, anticipated financial and operating results, strategies, future plans, contingencies and contemplated transactions of the company. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors which may cause or contribute to actual results of company operations, or the performance or achievements of the company or industry results, to differ materially from those expressed, or implied by the forward-looking statements. In addition to any such risks, uncertainties and other factors discussed elsewhere herein, risks, uncertainties and other factors that could cause or contribute to actual results differing materially from those expressed or implied for the forward-looking statements include, but are not limited to fluctuations in demand; changes to economic growth in the U.S. and U.S. government policies and regulations, including, but not limited to those affecting the medical fertility clinic industry. iGambit undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements as a result of certain factors, including those set forth in iGambit Inc.'s filings with the Securities and Exchange Commission.

Investor Relations Contacts:
Bill Robertson
Ph. No. 604 837 3835